| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/12/2008 | EP1896071A2 Methods and compositions with enhanced therapeutic activity |
| 03/12/2008 | EP1896047A1 Anti-gfralpha3 antibodies |
| 03/12/2008 | EP1895947A2 Improved method of treating degenerative spinal disorders |
| 03/12/2008 | EP1691763A4 Cab molecules |
| 03/12/2008 | EP1682866A4 Gel-shell beads with adsorbed or bound biomolecules |
| 03/12/2008 | EP1668031B1 Homogeneous preparations of il-29 |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1278855B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP0972048B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142320A Methods of detecting a phenotype of a polymorphic protein |
| 03/12/2008 | CN101142317A Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 03/12/2008 | CN101142236A Adam-9调节剂 Adam-9 modifiers |
| 03/12/2008 | CN101142233A Agents inhibiting the cathelin-like protein hcap18/ll-17 |
| 03/12/2008 | CN101141981A Fixed dosing of her antibodies |
| 03/12/2008 | CN101139574A LRP16 monoclonal antibody hybrid oncocyte strain and uses thereof |
| 03/12/2008 | CN101139398A Preparation method of heavy metal mercury monoclonal antibody |
| 03/12/2008 | CN101139397A Allogenic animal serum albumin as carrier protein for preparation of semiantigen-antibody |
| 03/12/2008 | CN101139396A Cadmium chelate complex monoclonal antibody and preparation method and usage thereof |
| 03/12/2008 | CN101139395A Preparation method of dextran monoclonal antibody |
| 03/12/2008 | CN101139394A Cytoplasma membrane surface antigen monoclonal antibody and uses thereof |
| 03/12/2008 | CN100374894C 凸轮环 Cam ring |
| 03/12/2008 | CN100374568C TAO protein kinases and methods of use thereof |
| 03/12/2008 | CN100374559C Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application |
| 03/12/2008 | CN100374466C Antibodies against human IL-12 |
| 03/12/2008 | CN100374465C Neutralizing antibodies against GDF-8 and uses therefor |
| 03/12/2008 | CN100374464C Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 03/12/2008 | CN100374463C Method for preparing nanometer realgar gel and nanometer realgar with biomacromolecule template to regulate shape and particle thereof |
| 03/12/2008 | CN100374457C Anti-IL-6 antibodies, compositions, methods and uses |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/12/2008 | CN100374159C Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists |
| 03/12/2008 | CN100374151C medicine compositions for generating immune and usage of prevention and treatment of amyloidogenic disease |
| 03/11/2008 | US7342110 Polynucleotides, host cells and vectors for antibodies against leukemia CD 33 antigen |
| 03/11/2008 | US7342109 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 03/11/2008 | US7342106 Human antihuman MCP-1 antibody and antibody fragment thereof |
| 03/11/2008 | US7342105 Antibody and use thereof |
| 03/11/2008 | US7342104 Antibodies against the PRO4320 polypeptide |
| 03/11/2008 | US7342103 Comprises DNAX interferon-like receptor subunit (DIRS) polypeptide for use in diagnosis and treatment of inflammation and blood disorders |
| 03/11/2008 | US7342101 Immunization against Coccidioides spp. fungi, protein and peptide antigens |
| 03/11/2008 | US7342096 PRO1879 polypeptide |
| 03/11/2008 | US7342093 nhibitor of Apoptosis (IAP) proteins, cancer |
| 03/11/2008 | US7342092 Vaccines as dosage forms; acute myeloblastic leukemia |
| 03/11/2008 | US7342091 Soluble cyclic analogues of β amyloid peptide |
| 03/11/2008 | US7342090 Peptide-mimetics are constrained in the three-dimensional structure to provide an increased immunogenicity to the epitope sequence |
| 03/11/2008 | US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders |
| 03/11/2008 | US7341866 Gene expression patterns; diagnosis, therapy disease |
| 03/11/2008 | US7341843 Analyzing antibodies/fragments thereof via enzyme-linked immunosorbent assay or radioimmunoassay, for diagnosis and therapy; vaccines |
| 03/11/2008 | US7341842 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 03/11/2008 | US7341740 Human mitochondrial proteins and polynucleotide encoding the proteins |
| 03/11/2008 | US7341730 Inhibitors of angiogenesis and tumor growth |
| 03/11/2008 | US7341728 Internalisation of virus into cells |
| 03/11/2008 | US7341727 M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
| 03/11/2008 | US7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 03/11/2008 | US7341721 Agent that interacts with MHC beta2-microglobulin HLA class 1 molecules located on the tumor cell surface |
| 03/11/2008 | US7341720 Targeting of glycoprotein therapeutics |
| 03/11/2008 | CA2300358C Novel phytase |
| 03/11/2008 | CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 03/08/2008 | CA2622504A1 Methods and compositions for inhibiting cell death or enhancing cel proliferation |
| 03/06/2008 | WO2008028192A2 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/06/2008 | WO2008028146A2 Novel protein compositions and systems for expression of desaturases |
| 03/06/2008 | WO2008028117A2 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 03/06/2008 | WO2008028002A1 Increasing nadph-dependent products |
| 03/06/2008 | WO2008027944A2 Antigenic protein conjugates and process for preparing same |
| 03/06/2008 | WO2008027942A2 Combination hepatitis c virus antigen and antibody detection method |
| 03/06/2008 | WO2008027581A1 Mcrp antagonists and their uses |
| 03/06/2008 | WO2008027338A2 Antagonistic human light-specific human monoclonal antibodies |
| 03/06/2008 | WO2008027236A2 Multispecific antibodies |
| 03/06/2008 | WO2008026720A1 Antibody capable of enhancing activation of blood coagulation factor viii |
| 03/06/2008 | WO2008025964A2 Antibodies to an epitope of agr2. assays and hybridomas |
| 03/06/2008 | WO2008025744A1 Extra-cellular production of recombinant proteins |
| 03/06/2008 | WO2007147975A3 Antigenic surface structure of sperm cells associated with the y chromosome |
| 03/06/2008 | WO2007143711A3 Blood-brain barrier targeting antibodies |
| 03/06/2008 | WO2007136789A3 Methods of preventing, treating or ameliorating enhanced respiratory disease via innate immune mechanisms |
| 03/06/2008 | WO2007119179A3 Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages |
| 03/06/2008 | WO2007109749A3 Methods for preventing and treating amyloidogenic diseases |
| 03/06/2008 | WO2007100643A3 Methods of using antibodies against human il-22 |
| 03/06/2008 | WO2007087412A3 Tat-036 and methods of assessing and treating cancer |
| 03/06/2008 | WO2007084922A3 Compositions and methods for humanization and optimization of n-glycans in plants |
| 03/06/2008 | WO2007081804A3 Regulators of nfat |
| 03/06/2008 | WO2007080404A3 Leptin ligand |
| 03/06/2008 | WO2007062101A3 Intraocular pressure-regulated early genes and uses thereof |
| 03/06/2008 | WO2006120473A3 Mhc class i and ii peptide antigens derived from tumour antigen 5t4 |
| 03/06/2008 | WO2006118772A9 Fcrn antibodies and uses thereof |
| 03/06/2008 | WO2003076568A3 Immunotherapeutics for biodefense |
| 03/06/2008 | US20080060100 Polypeptide Having 5 Fatty Acid Desaturating Activity, Polynucleotide Coding for the Polypeptide, and Use Thereof |
| 03/06/2008 | US20080060092 Humanized glycoproteins isolated from plant bioreactors |
| 03/06/2008 | US20080060089 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom |
| 03/06/2008 | US20080058762 Induction And Maintenance Of Tolerance To Composite Tissue Allografts |
| 03/06/2008 | US20080058507 Using bind elute process to isolate preferential immunoglobulin components; antibody purification |
| 03/06/2008 | US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 03/06/2008 | US20080058429 Diagnosis Of Primary Open Angle Glaucoma |
| 03/06/2008 | US20080058277 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |
| 03/06/2008 | US20080058258 Growth Factor |
| 03/06/2008 | US20080058257 Semaphorin protein; gene expression on surface dendritic cells |
| 03/06/2008 | US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression |
| 03/06/2008 | US20080058248 Toxin Complex Proteins and Genes from Xenorhabdus bovienii |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |